The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Biological Availability

This is a "connection" page, showing publications Olatoyosi Odenike has written about Biological Availability.
Connection Strength

0.016
  1. Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies. J Clin Oncol. 2004 Dec 01; 22(23):4816-22.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.